Possibilities and limitations of surgical treatment of adrenocortical carcinomas: 74 cases;Possibilités et limites du traitement chirurgical des cortico-surrénalomes malins. À propos d'une série de 74 cas

Chirurgie

Volumn 123, Issue 1, 1998, Pages 61-66

  Chapuis, Y ^a   Icard, P ^a   Barei, R ^a   Pitre, J ^a   Dousset, B ^a   Louvel, A ^a   Luton, J P ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Adrenocortical carcinomas; Prognosis; Surgical treatment

Indexed keywords

ADOLESCENT; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LYMPHADENECTOMY; MALE; MIDDLE AGED; MORTALITY; NEPHRECTOMY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE; ADRENAL CORTEX CARCINOMA; CANCER SURGERY; DISEASE CLASSIFICATION; HORMONE RELEASE; INFERIOR CAVA VEIN; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; RECURRENT CANCER; SURGICAL MORTALITY;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; SURVIVAL RATE;

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOTANE; SURAMIN;

EID: 0031991790     PISSN: 00014001     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-4001(98)80040-8     Document Type: Article

References (10)

1. Icard P, Chapuis Y, Louvel A. Survival rates and prognosis factors in adrenocortical carcinoma. A study of 41 surgically treated patients in a single center. World J Surg 1992 ; 16 : 753-8
2. Icard P, Chapuis Y, Andréassian B, Bernard A, Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992 ; 112 : 972-9
3. Chapuis Y, Icard P. Cortico-surrénalomes malins. In: Chapuis Y, Peix JL, eds. Chirurgie des surrénales, Paris : Arnette ; 1994. p 61-73
4. Chapuis Y, Icard P, Louvel A. Le cortico-surrénalome malin. Rev Fr Endocrinol Clin 1995 ; 36 : 93-104
5. Weiss LM, Medeiors LJ, Vickery AL. Pathologic features of prognosis significance in adrenocortical carcinoma. Am J Surg Pathol 1989 ; 13 : 202-6
6. Icard P, Louvel A, Chapuis Y. Fréquence et valeur pronostique de l'extension ganglionnaire et rénale dans les corticosurrénalomes. Lyon Chir 1990 ; 86 : 151-2
7. Luton JP, Cerdas S, Billaud L. Adrenocortical carcinoma. Clinical features, prognostic factors and therapeutic results in 105 patients from a single center (1963-1987). N Engl J Med 1990 ; 322 : 1195-201
8. Jarabak J, Rice K. Metastatic adrenal cortical carcinoma. Prolonged regression with mitotane therapy. JAMA 1981 ; 246 : 1706-7
9. Van Slooten H, Moolenaar AJ, Van Seters AP, Smeenk D. The treatment of adrenocortical carcinoma with op'DDD: prognostic simplications of serum level monotoring. Eur J Cancer Clin Oncol 1984 ; 20 : 47-53
10. Schlumberger M, Brugieres L, Gicquel C. Travagli JP, Droz JP, Parmentier C. 5-fluorouracil, doxorubicin and cisplatinin as treatment for adrenal cortical carcinoma. Cancer 1991 ; 67 : 2997-3000